Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
ALBIREO PHARMA, INC. has filed 1,239 SEC EDGAR filings since 28 Mar 2005

SEC filing history

Showing 426-450 of 938 matching filings.

Per page
25
Current page
18
3

PRIMARY DOCUMENT

Filing date
04 Dec 2017
Reporting date
01 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-220958

S-3/A - AMENDMENT NO. 1

Filing date
16 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K EARNINGS RELEASE 093017

Filing date
14 Nov 2017
Reporting date
14 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-220958

S-3

Filing date
13 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

FORM 8-K

Filing date
13 Oct 2017
Reporting date
13 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
29 Sep 2017
Reporting date
27 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Sep 2017
Reporting date
27 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33451

8-K

Filing date
28 Sep 2017
Reporting date
25 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Aug 2017
Reporting date
21 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Aug 2017
Reporting date
21 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Aug 2017
Reporting date
21 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Aug 2017
Reporting date
21 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Aug 2017
Reporting date
21 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Aug 2017
Reporting date
21 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-33451

NT 10-Q

Filing date
15 Aug 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2017
Reporting date
16 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2017
Reporting date
16 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2017
Reporting date
16 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2017
Reporting date
16 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2017
Reporting date
16 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .